The induction of apoptosis by contrast media (CM) and mannitol (M) was investigated in the hearts and kidneys of 12-mo-old male SHR rats. Ten groups of 3 SHR rats received a dose of 5 ml/kg of one of the following: Hypaque (H)-30. H-60, H-76, Omnipaque (O)-140, O-350, mannitol (M)-4%, M-9%, M-19%, M-27%, or saline (S). DNA fragmentation was detected using the terminal deoxynucleotidyl transferase-mediated [TdT] dUTP nick-end labeling (TUNEL) method, and the morphology characteristics of apoptosis were confirmed in cardiac and renal cells. The immunoreactivities of Bcl-2, Bax, and p53 were assessed immunohistochemically in the kidneys. Apoptosis occurred in cardiac myocytes and renal tubular and glomerular cells as well as in vascular endothelial and smooth muscle cells of the heart and kidneys. The high frequency of apoptosis correlated significantly with the increase in the osmolality of the H, O, and M. The increased Bax, the increased p53, and the decreased Bcl-2 immunoreactivities were detected in Hor O-treated, but not in M-treated, rats. These findings suggest that CM and M activate cardiac and renal apoptosis by different mechanisms and that the apoptotic process may be implicated in acute heart and renal damage.
INTRODUCTION
In 2 vital organs, the heart and the kidney, apoptosis can be triggered by a wide variety of stimuli resulting from diverse pathological conditions, such as hypoxia (2, 19, 36) , ischemia (15, 16, 35, 37) , ischemia-reperfusion injury (17, 34) , heart failure (1, 28) , and kidney failure (2, 34) . There have been no reports suggesting that contrast medium (CM) and mannitol (M) can trigger cardiac apoptosis. Recently, it has been reported that renal tubular apoptosis was induced by a radiocontrast agent, an ionic CM-sodium iothalamate (2, 19) .
Intravenous administration of CM is widely used in angiography, urography, or computed tomography for the evaluation of various vascular beds and organ functions (22) . The contrast agents have been reported to induce cardiovascular (7) and renal toxicity (3, 7, 20, 32) in patients. CM has been found to be nephrotoxic in old male SHR rats (11) (12) (13) (14) . A recent study of this experimental model revealed that the nephrotoxicity induced by CM and M correlated significantly with an increase in their osmolalities (12) . Light microscopy disclosed that some renal cells showed nuclear chromatin condensation, nuclear fragmentation, cell shrinkage, and compact cytoplasm, all of which are indicative of apoptosis (14) . Moreover, while examining cardiac tissues, we noticed that some myocytes in necrotic and hemorrhagic areas also appeared to show the morphological characteristics of apoptosis (14) . Therefore, it appears that besides necrotic cell death, apoptotic cell death may be implicated in the cardiac and renal toxicity observed following administration of CM and M in old SHR rats. The present investigation examines the apoptotic phenomena in more detail in this animal model. The hypothesis that CM and M can induce apoptosis was tested in the present study using the terminal deoxynucleotidyl transferase-mediated [TdT] dUTP nick-end labeling (TUNEL) method for in situ detection of DNA fragmentation. The toxic effects of CM or M on the heart and kidneys were evaluated using routine histopathological methods. The immunoreactivities of Bcl-2, Bax, and p53 proteins were assessed using immunoperoxidase techniques. The present study was performed to evaluate (a) the occurrence of apoptosis in the heart and kidneys of SHR rats treated with several concentrations of Hypaque (H), Omnipaque (0), or mannitol (M); (b) the correlation of the frequency of apoptotic cells with the osmolality of the tested agent; and (c) the potential mechanisms that trigger cardiac and renal apoptosis.
MATERIALS AND METHODS
Animals,. Weanling male SHR rats were purchased from Charles River Breeding Laboratories (Wilmington, MA), placed in individual cages, and allowed water and rat chow ad libitum until they attained the required age of 12 mo. The experimental protocol was approved by (11) (12) (13) (14) . On the day of the experiment, the 12-mo-old SHR rats were anesthetized with sodium pentobarbital (45 mg/kg, i.p.). Groups of 8-10 SHR rats were given one of the following agents or saline (S) (into their tail veins) at a dose of 5 ml/kg over a period of I min. Group 1 received S (controls); group 2 received H-30 ; group 3 received H-60; group 4 received H-76; group 5 received 0-140; group 6 received 0-350; group 7 received M-4%; group 8 received M-9%; group 9 received M-19%; and group 10 received M-27%. Of these treated rats, 3 SHR rats from each group were randomly selected for the apoptotic study. Volume of CM. Since the volume of CM is one of the risk factors for the CM-induced renal damage (6) , we administered the CM to SHR rats at a dose of 5 ml/kg in order to magnify the risk factor ( 1 -14) . The dose used in this study was the equivalent dose (350 ml/70 kg body weight) for a human and exceeded somewhat the recommended human dose (maximum dose, 300 ml/70 kg body weight), which is intended to minimize the incidence of renal dysfunction induced by the CM in patients with renal disease (6) . However, an excess of the recommended human dose is occasionally administered clinically in angiographic studies (6) .
Pathological Study. The day after the injections (H, 0, M, or S), the animals were again anesthetized with pentobarbital. The left kidney and heart of each animal were excised, fixed in 10% buffered formalin, and embedded in paraffin. Hematoxylin-eosin, Alcian blue/periodic acid-Schiff, Verhoeff-van Gieson, and Masson's trichrome stains were used for histopathologic evaluation.
The CM-induced nephrotoxicity (glomerular sclerosis, tubular dilation and casts, tubular cell degeneration and necrosis, vasculitis of small arteries, and interstitial lymphocytic infiltration) was graded in renal tissue sections on a semiquantitative scale of 0 to 4+, as reported previously (12) (13) (14) .
DNA fragmentation was detected using the TUNEL method (25) . The commercial TACS@ in situ apoptotis detection kit (Trevigen, Inc., Gaithersburg, MD) was used in this study. The formalin-fixed, paraffin-embedded sections were incubated with proteinase K (20 pLg/ml) for 15 min at room temperature (RT) and were treated with 2% H~O~ for 5 min to inactivate endogenous peroxidase. The sections were then incubated with a reaction mixture (consisting of TdT, MnCI2, and dNTP) in a humidified chamber at 37°C for 1 hr. The incubation was terminated with the stop buffer, and then the sections were incubated with streptavidin-horseradish peroxidase for 10 min and developed with insoluble blue substrate (TACS Blue Label) for 3-5 min; finally, sections were counterstained with eosin. For positive control staining, the sections were pretreated with DN buffer (30 mM Tris-HCI, pH 7.2; 140 mM potassium cacodylate; and 4 mM MgC'2) followed by DNase I ( 1 ~,g/ml; Sigma Chemical Co., St. Louis, MO) for 10-30 min at RT. For negative control staining, the sections were treated as described above but TdT was omitted.
For detecting immunoreactivity of apoptosis-related factors, Bcl-2 and Bax, the avidin-biotin-peroxidase method was used in the formalin-fixed, paraffin-embedded tissue sections (21) . The renal tissue sections were pretreated with Citra antigen-retrieval solution (Bio-Genex, San Ramon, CA) in a microwave oven associated with a pressure cooker. Endogenous peroxidase was inactivated with 0.3% H202 in methanol at RT for 30 min. Then the sections were pretreated with TNK solution (100 mM Tris, pH 7.6; 550 mM NaCI; and 10 mM KCI) containing 2% bovine serum albumin (BSA) (ICN Biomedicals, Inc., Aurora, OH), 0.1 % Triton X-100 (Labchem, Inc., Pittsburgh, PA), and 1 % normal goat serum (Vector Laboratories, Burlingame, CA) at RT for 30-45 min. The sections were incubated overnight with polyclonal rabbit anti-rat/mouse Bcl-2 and Bax antibodies (1:
1,000 dilution) (PharMingen, San Diego, CA) at 4°C. After the sections were rinsed in phosphate-buffered saline (PBS) containing 0.1% BSA, they were incubated I hr with the second antibody, biotinylated goat anti-rabbit serum (1:200 dilution) (Vector Laboratories) and then incubated for 30 min with avidin-biotin-peroxidase complex (Vector Laboratories). After being washed in PBS, the sections were developed for 10 min with 0.1 M Tris buffer containing 3,3'-diaminobenzidine hydrochloride (DAB) and 0.1 % H202 and were counterstained for 3 min with hematoxylin.
For immunostaining of p53, the paraffin sections were preincubated at 80°C overnight with 10 mM sodium citrate buffer (pH 6.0) for epitope retrieval (26) . The sections were treated with 0.3% H20, and 10% normal horse serum and were incubated overnight at 4°C with primary monoclonal antibody p53 (ab-3)/PAb 240 (20 pLg/ml) (Oncogene) and were then incubated with biotinylated anti-mouse antibody (Vector Laboratories) for 1 hr at RT. The incubation with an avidin-biotin complex, development with DAB, and counterstaining used were the same as those described above. For positive controls, sections of human colon carcinoma (Oncogene) and murine thymus were concomitantly stained.
Method for Counting Apoptotic Cells. Counting for apoptotic cells was based not only on the color produced by TUNEL method but also on the morphologic identification. Only cells that had a black color, an elongated morphology, and a centrally localized nucleus were included in the count of apoptotic myocytes. In longitudinal sections of myocardium, interstitial cells appeared to be elongated in shape; these cells were not included in the count. Neither large nor small round cells in sections of heart and kidneys were included, because these cells represent macrophages and lymphocytes, respectively. A cluster of apoptotic bodies occupying the area of a single cell of a renal tubule was counted as 1 apoptotic cell. Apoptotic bodies that were undergoing phagocytosis and digestion by neighboring epithelial cells of renal tubules were usually very tiny, faintly stained spots; therefore, these bodies were not counted.
Statistics. The number of apoptotic cells in the cardiac and renal sections was counted in 50 randomly selected microscopic fields at a magnification of X 250. The quantitative data of apoptotic cells were presented as means ± SD per square millimeter of tissue sections. The association between the degree of osmolality and the frequency of apoptosis was examined by using nonparametrics procedures: Jonckheere-Terpstra test and linearby-linear association test. A value of p s 0.05 was considered to indicate significance.
RESULTS

Histopathologic Findings
The hearts of the S-treated SHR rats showed mild interstitial fibrosis as the only cardiac lesion. In contrast, H, 0, and M caused myocyte necrosis (Fig. lA ), interstitial hemorrhage (Fig. 1B) , and edema in the hearts. Massive hemorrhage was usually associated with myocyte necrosis (Fig. 1B ). Rupture of an arterial wall associated with severe hemorrhage was found in the left ventricle in 1 rat treated with H-60 ( Fig. 1 C) . No inflammation was detected in the cardiac sections of SHR rats treated with H, 0, or M.
CM-and M-induced renal toxicity has been described elsewhere (11) (12) (13) (14) . No remarkable alterations were found in the kidneys of the S-treated SHR rats (Fig. ID) . In contrast, H, 0, and M usually induced glomerular fibrosis and thickening of Bowman's capsules (Fig. IE, F As noted previously (12) , high osmolar CM induced more severe renal damage than did low osmolar CM. The renal lesions were more severe in rats treated with M-19% or M-27% than in rats given M-4% or M-9%. 0-350 caused more severe glomerular and interstitial lesions than did 0-140. The lesions induced by H-60 and H-76 were more severe than those observed in the kidneys of H-30-treated rats.
Detection of Apoptosis
In the hearts of the H-, 0-, and M-treated rats, the TUNEL method showed positive nuclear reactions in myocytes ( Fig. 2A ) and in endothelial and smooth muscle cells of blood vessels (Fig. 2B ). Apoptosis in these cells was confirmed by morphologic identification of nuclear chromatin condensation, cell shrinkage, and deeply stained compact cytoplasm. Apoptotic cells were usually adjacent to massive hemorrhage ( Fig. 2A) .
The kidneys of the H-, 0-, and M-treated rats exhibited apoptosis in a variety of cell types, including parietal and visceral cells of the glomeruli (Fig. 2C ), endothelial cells of the glomerular tufts, endothelial cells of afferent arterioles (Fig. 2C ), endothelial and smooth muscle cells of the interlobular arteries (Fig. 2D ), and tubular epithelial cells of the proximal and distal tubules ( Fig. 2E ). Varying sizes of apoptotic bodies were usually clustered together in cytoplasm of tubular epithelial cells (Fig. 2E ). Compared with apoptotic cells in rats treated with H, 0, or M, the apoptotic cells in rats treated with S were rarely found.
Frequency of Apoptotic Cells Relative to Osmolality of CM
The frequency of apoptotic cells in the hearts and kidneys was significantly higher in rats treated with highosmolar CM than that in rats given low-osmolar CM (Table I and Figs. 3 and 4 ). As shown in Table I , a small number of apoptotic cells was detected in the hearts (0.80 ± 0.60) and in the kidneys (0.27 ± 0.04) of S-treated rats.
In M-4%-treated rats, the number of apoptotic cells in the hearts (0.77 ± 0.60) was comparable to that same value in S-treated rats, but the number of apoptotic cells in the kidneys (0.43 ± 0.04) was higher than that same value in S-treated rats (p < 0.002). The numbers of apoptotic cells in the hearts ( 1.17 ± 1.13) and in the kidneys (0.79 ± 0.16) of M-9%-treated rats were significantly higher than the same values in Sor M-4%-treated rats (p < 0.002). M-19% led to a significant increase in the number of apoptotic cells in the hearts (1.76 ± 2.19) and in the kidneys (1.35 ± 0.38), compared with that seen in S-, M-4%-, or M-9%-treated rats (p < 0.002). M-27% resulted in the highest increase in the number of apoptotic cells in the hearts (1.95 ± 1.80) and in the kidneys (1.57 ± 0.36), compared with these same numbers in rats given S, M-4%, M-9%, or M-19% (p < 0.002).
In O-350-treated rats, the numbers of apoptotic cells in the hearts (1.24 ± 0.46) and in the kidneys (0.74 ± 0.29) were significantly higher than those same values in the hearts (1.13 ± 0.58) and in the kidneys (0.34 ± 0.03) of O-140-treated rats (p < 0.002). The number of apoptotic cells induced by 0-140 and 0-350 was significantly different than that same value in S-treated rats (p In H-30-treated rats, the numbers of apoptotic cells in the hearts (1.06 ± 0.02) and in the kidneys (0.84 ± 0.30) were significantly higher than those same numbers in Streated rats (p < 0.002). H-60 induced a much higher increase in the number of apoptotic cells in the hearts (2.00 ± 1.18) and in the kidneys ( 1.24 ± 0.31) than did H-30 (p < 0.002). H-76 resulted in the highest increase in the number of apoptotic cells in the hearts (4.92 ± 0.81) and in the kidneys (3.19 ± 0.32) among the rats treated with S, H-30, or H-60 (p < 0.002).
Immunoreactivity of Apoptosis-Related Factors in Kidneys
The immunoperoxidase staining method for p53 showed nuclear localization. Immunoreactivity for p53 in renal tubular cells (Fig. 2F ) was stronger in the H-76-, 0-140-, or 0-350-treated rats than in the S-treated rats.
The immunoperoxidase staining method for Bcl-2 in the S-treated rats showed coarse granules in the cytoplasm, which were diffusely distributed broadly amongst the tubular epithelial cells, parietal glomerular epithelial cells, and vascular smooth muscle cells. Compared with the reaction in the S-treated rats, the immunoreaction for Bcl-2 in the H-76or 0-350-treated rats appeared to consist of fine granules in the cytoplasm of renal epithelial cells and smooth muscle cells (Fig. 2G ).
The immunoperoxidase staining method for Bax in the H-76or O-350-treated rats consisted of an intense reaction in vascular smooth muscle cells of all the medial layers ( Fig. 2H ), but only a slight reaction was found in scattered smooth muscles in S-treated rats. No significant change in immunoreactions for Bcl-2, Bax, and p53 was detected in the M-19% or M-27% rats.
DISCUSSION
CMor M-Induced Renal Apoptosis
Sodium iothalamate, an ionic CM, has been reported to induce tubular epithelial apoptosis in the kidneys of salt-depleted, uninephrectomized rats (2, 19) . The present study adds 2 other CMs (0 and H) and M as agents that also trigger renal apoptosis. In situ detection of DNA fragmentation revealed a variety of renal cells undergoing apoptosis, including (a) the tubular epithelial cells; (b) the glomerular epithelial cells; (c) the endothelial cells of the glomerular capillary tufts, afferent arterioles, and interlobular arteries; and (d) the smooth muscle cells of the interlobular arteries. Our findings suggest that both tubular cell necrosis and tubular cell apoptosis are implicated as causative factors in the pathogenesis of acute renal failure. The elimination of vascular endothelial and smooth muscle cells in small arteries and arterioles by apoptosis may contribute to the reduction of blood supply to glomeruli and to hemorrhage. Ischemia (15, 16, 35, 37) and ischemialreperfusion (16, 34) have been proposed as inducers of renal apoptosis. However, the mechanisms by which CM or M activated renal apoptosis have not been defined. It has been demonstrated that the administration of high-osmolar CM caused prolonged renal vasoconstriction (23) and produced marked medullary hypoxia (2, 19) . It was recently suggested that CM-induced nephrotoxicity could be mediated by renal ischemia, hypoxia, and a direct vasotoxic effect of the iodinated molecules (3, 20, 24) . Evidence supporting a direct vasotoxic effect of CM on endothelial cells has been presented in an ultrastructural study (31) , in which CM uptake by endothelial cells through pinocytotic vesicles and intercellular junctions was observed in CM-treated rats. In addition, endothelin, a potent renal and systemic vasoconstrictor agent, has been reported to be increased in blood plasma and urine after CM administration (27) . The present study demonstrated that CM induced thickening of the arterial medial layers, narrowing of the lumen, and obliteration of glomerular capillary tufts. Whether these morphologic findings support ischemia-induced apoptosis remains to be resolved.
CMor M-Induced Cardiac Apoptosis
The cardiomyocyte is one of the terminally differentiated cell types; however, evidence indicates that cardiomyocytes can undergo apoptosis in humans and in rats by hypoxia, ischemia, reperfusion, overload, heart failure, and allograft rejection (see 5 for review). It has been reported that myocyte apoptosis occurs in the heart of untreated 16to 30-wk-old SHR rats (4, 9, 18) . Vascular endothelial and smooth muscle cell apoptosis were rarely found in 30-wk-old untreated SHR rats (9) . However, smooth muscle cell apoptosis can be induced by antihypertensive drugs (enalapril, losartan, and nifedipine) in 10or 11-wk-old SHR rats (8) . There has been only I report in the literature that indicated that the 3 ionic CMs, Renografin-76&copy; (diatrizoate meglumine diatrizoate sodium), MD-76&copy; (diatrizoate meglumine diatrizoate sodium), and Angiovist-370&copy; (meglumine diatrizoate), caused ultrastructural changes (cell shrinkage and nuclear condensation) indicative of apoptosis in aortic endothelial cells of rats (31 ) . Our results demonstrate for the first time apoptosis occurring in cardiac myocytes, endothelial cells, and vascular smooth muscle cells in the hearts of CMor M-treated SHR rats. The elimination of cardiomyocytes by apoptosis combined Bowman's capsule and basement membranes of glomerular tufts and tubules were thin and PAS positive e (purple color). X250. E) AB/PAS-stained section of H-60-treated rat shows thickening of Bowman's capsule and basement membranes of tufts and tubules (purple color), tubular dilatation, proteinaceous casts, obliteration of an arterial lumen, and adventitial lymphocytic infiltration. X250. F, G) AB/PAS-stained sections of kidneys of rats treated with 0-350 (F) or M-27% (G) show thickening of Bowman's capsule and basement membranes of tuft and tubules (purple color), tubular dilatation, casts, and interstitial lymphocytic infiltration. X250. H) H&E-stained section of kidney of M-27%-treated rat shows vasculitis, which was characterized by narrowing of the lumen, intimal fibrinoid necrosis, medial thickening and inflammatory infiltration, and adventitial lymphocytic infiltration. X250. A, B) and kidney (C-H) and immunoreactivity of p53 (F), Bcl-2 (G), and Bcrx (H) of CM or M-treated SHR rats. A positive reaction of DNA fragmentation is indicated by a black color (A-F). The cytoplasm is counterstained with eosin. A) Apoptotic cardiomyocytes associated with hemorrhage are seen in the heart of H-76-treated SHR rat. X400. B) Apoptosis in vascular endothelial and smooth muscle cells is found in a small artery of the heart of M-27%-treated SHR rat. X400. C) Apoptosis is shown in parietal and visceral cells of a glomerulus and in endothelial cells of an arteriole in the kidney of H-76-treated SHR rat. X250. D) Apoptosis in endothelial and smooth muscle cells of a small artery is evident in the kidney of H-76-treated SHR rat. X250. E) Numerous apoptotic bodies are readily with cardiac necrosis may constitute a cardiac toxic event, suggesting that cardiac apoptosis may participate in the pathogenesis of CMor M-induced cardiomyopathy. The elimination of endothelial cells and smooth muscle cells by apoptosis may lead to the reduction of blood supply to the myocardium or to hemorrhage. The mechanisms responsible for cardiac apoptosis by CM or M are not known. It has been suggested that cardiomyocyte apoptosis may be related to increased angiotensin-converting enzyme activity in the left ventricle of adult SHR rats (9) . Whether this is also the mechanism of CMor M-induced cardiac apoptosis has not been determined.
Immunoreactivity of Apoptosis-Related Factors
Apoptosis is regulated by several apoptosis-related proteins, such as tumor-suppressor protein (p53), Bcl-2like proteins, and Bax-like proteins (see 5, 29, 33 for review).
An increased level of p53 can promote apoptosis (5, 29, 33) . Enhanced p53 expression was associated with cardiomyocyte apoptosis as a result of hypoxia in the rat and of heart failure in the dog (5) . The present study shows increased p53 immunoreactivity in the renal cells of CM-treated SHR rats. These observations suggest a role for p53 in the pathogenesis of apoptosis in CM-treated SHR rats. However, no differences in p53 immunoreactivity were detected between in M-treated and Streated SHR rats, indicating that the mechanism for Minduced apoptosis is different from that for CM-induced apoptosis.
Bcl-2 family members (Bcl-2, Bcl-x, and Bcl-x,8) prevent apoptosis, whereas Bax family members (Bax, Bak, and Bcl-xS) promote apoptotic cell death (5) . The alteration of the balance between Bcl-2-like proteins and Baxlike proteins may determine the induction of, or inhibition of, apoptosis. In the kidneys of diabetic mice, decreased Bcl-2 and increased Bczx gene expression were associated with tubular apoptosis (30) . Our study shows that the high levels of Bax immunoreactivity and the low levels of Bcl-2 immunoreactivity correlated with a high frequency of apoptotic cells in vascular smooth muscle cells in CM-treated SHR rats. Although the Bcl-2/Bax ratio was also decreased in the renal tubular cells in CMtreated SHR rats, no alteration of Bcl-2/Bax ratio was found in the smooth muscle and tubular epithelial cells of M-treated rats. Our results are in agreement with the report of Ortiz and Neilson (29) , which stated that Dmannitol did not decrease Bcl-2 and increase Bax gene expression in the renal cortex. Therefore, it seems likely that the increased Bcl-2 and the decreased Bax immu- noreactivity play a role in promoting apoptosis in CMtreated but not in M-treated SHR rats.
Correlation of Apoptosis with CM Osmolality
The CM that were tested have osmolalities ranging from about 300 mOsm for isotonic nonionic 0-140 to greater than 1,500 mOsm for ionic H (22) . It has been suggested that hyperosmolality may be one factor in CM toxicity to endothelium (31) . We have previously reported that CM-induced renal toxicity results, in part, from the high-osmolar CM (12) . The results of the present study also indicate that osmolality may be a factor in CMor M-induced cardiotoxicity. Moreover, the osmolality closely correlated with the increased frequency of apoptotic cells. Our results (Table I) observed in the cytoplasm of distal tubular epithelial cells of the kidney of H-60-treated SHR rat. X250. F) p53 is detected at high levels in the nuclei of tubular cells of the kidney of H-76-treated SHR rat. X400. G) Decreased Bcl-2 immunoreactivity is evident in the cytoplasm of endothelial and smooth muscle cells of a small artery as well as in tubular epithelial cells in the kidney of H-76-treated SHR rat. X400. H) Increased Bax immunoreactivity is conspicuous in the cytoplasm of endothelial cells and vascular muscle cells of the kidney of H-76-treated SHR rat. X400. Our results indicate a correlation between the osmolality of M and the degree of apoptosis induced in the heart and kidneys. In addition, the present study demonstrates that M induced not only acute renal injury, which has been reported by Dorman et al (10) , but also acute cardiac injury in these old SHR rats, to which apoptosis may contribute.
In conclusion, this report presents evidence demonstrating that apoptosis can be induced by CM and M in the heart and kidneys of aging male SHR rats. Apoptotic cell death of parenchymal cells (cardiac myocytes, tubular epithelial cells, vascular endothelial, and smooth muscle cells) could have detrimental effects on these organs and may contribute to acute heart and kidney failure. There was a direct correlation between the frequency of apoptosis and the osmolality of the CM and M. The decreased Bcl-2 immunoreactivity and the increased Bax and p53 immunoreactivities were found in CM-treated SHR rats but not in M-treated rats, which indicates that the induction of apoptosis by CM or M was conducted via different pathways. FDA) for his critical review and advice. We are also indebted to Dr. Kooros Mahjoob from the Division of Biometrics 1 (CDER, FDA) for his assistance in performing statistical analyses.
